Nov 11, 2024, 23:39
LDCT screening for lung cancer substantially reduces mortality from lung cancer
“LDCT screening for lung cancer substantially reduces mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses.
This review is based on the 9th CT screening symposium of the IASLC, which focuses on the major themes pertinent to the successful global implementation of LDCT screening and develops a strategy to further the implementation of lung cancer screening globally.
Learn More.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 4, 2024, 11:51
Dec 4, 2024, 06:56
Dec 4, 2024, 06:56
Dec 4, 2024, 06:19
Dec 4, 2024, 00:18
Dec 4, 2024, 00:09